Financial Investment Network reporter Liu Min
Mindray Medical was "crossed the threshold" by the organization.
202 1 among the listed companies surveyed by institutions in 2002, 509 companies accepted 100 institutions. Among them, 67 companies accepted 500 organizations, and 1 1 companies accepted intensive surveys of more than 1000 organizations. It is worth mentioning that in 20 19, Hikvision has only 1 home, and in 2020, there will only be 3 companies: Mindray Medical, Hikvision and Desai Siwei.
In 20021year, Mindray Medical became the only company that received more than 2000 people. Previously, Mindray Medical surpassed Hikvision to become the most popular company in 2020. In 20021year, the company only received 10 batches of institutional research, but the total number of participating institutions reached 2 102, with an average of more than 200 companies conducting research each time. Next came Huichuan Technology, which was surveyed by 1.697 institutions, while Zhongke Chuangda, Chuanyin Holdings and Huafeng Measurement and Control were surveyed by 1.263, 1.258 and 1.98 institutions respectively. In 2026, 5438+0, Hikvision Receiving Agency. Meanwhile, Haupt, Zhongwei Company, Zhao Yi Innovation, Huayang Group and Aimeike were investigated 1 1,000 times.
Mindray Medical is a manufacturer of high-tech medical equipment in China. Its main products cover life information and support, in vitro diagnosis and medical imaging. In the first three quarters of 20021,the company realized operating income of1939.2 billion yuan, a year-on-year increase of 20.72%; The net profit of returning to the mother was 6.663 billion yuan, a year-on-year increase of 24.23%.
Compared with the same period in 2020, the growth rate of Mindray Medical's performance in the first three quarters showed a significant decline. In this regard, Mindray Medical said in a recent survey that due to the COVID-19 epidemic, orders for anti-epidemic related products broke out in the second quarter to the third quarter of 2020, which brought extremely high base pressure to the second and third quarters of 2002/KLOC-0.
Judging from the frequency of research, * * * 4 1 1 listed company 202 1 year obtained more than 10 times, and 15 company obtained more than 50 times. Among them, Ou Ke billion yuan is the most concerned. 202 1, the company * * received 1 19 investigations from 187. The company's main product is CNC blades. On October 4th, 2022/kloc-0, Yi said on the interactive platform that in view of the continuous increase in the prices of the company's main raw and auxiliary materials, the company issued a notice of product price adjustment, and since October 4th, 2022/kloc-0, the prices of some products have been raised by 2%-6%.
From the perspective of industry distribution, the stocks intensively researched in 20021mainly come from electronics, medicine, biology, machinery and equipment, chemical industry and other industries. Among them, the top five listed companies in reception institutions are from medical and health care equipment, electrical components and equipment, system software, communication equipment and semiconductor equipment.
Most of the hot stocks surveyed rose.
Judging from the stock price performance, many stocks in the hot stocks studied by 202 1 institutions have risen. Among the 1 1 companies of more than 1,000 research institutions, 9 companies achieved different degrees of growth in 20021. Among them, Huayang Group's share price doubled by 105%, while Aimeike, Huafeng Measurement and Control and Haupt increased by 48.065%, 438+0%, 37.36% and 30.49% respectively. Mindray Medical's share price, the most favored by institutions, fell by 10%, while Zhongwei Company fell by 19.66%.
Huayang Group, the biggest gainer among the hot stocks, received a total of 27 institutions 1050 surveys on 202/kloc-0. 202 1 12 16, Huayang Group said that since 20021,it has undertaken projects including Changan Ford, Beijing Hyundai, Dongfeng Honda, Great Wall, Changan, Guangzhou Automobile, Geely, BYD, BAIC, Chery, Baidu, Weilai and Weiwei.
In 20021year, Aimeike, a leading medical and aesthetic enterprise, only accepted three surveys, but the cumulative number of institutions reached 1003, which means that more than 300 institutions participated in the survey on average. Aimeike is an innovative leading enterprise in the field of biomedical soft tissue repair materials in China. In the first three quarters of 20021,the company achieved operating income of102.3 billion yuan, a year-on-year increase of 120.29%. The net profit of returning to the mother was 709 million yuan, a year-on-year increase of 144.09%.
It is worth noting that companies favored by star private equity funds and conducting research have always been the focus of market attention. Gao Yu Capital, which has made frequent moves in the A-share market in recent two years, has also intensified its research on 202 1. Wind data shows that Gao Lin Capital 202 1 * * investigated 103 companies, totaling 160 times. The top three stocks in terms of attention are Huichuan Technology, Changchun Gaoxin and Mindray Medical.